Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma

doi:10.3748/wjg.v22.i8.2630

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7064)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

508

WORD

235

HTML

2857

Tables (1-4)

275

Sum=3875

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1156

Download

2010

Sum=3166

Feb 28, 2016 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Feb 28, 2016; 22(8): 2630-2635
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2630

Table 3 Alterations of alpha fetoprotein levels in case 2

	Apr 2012	July 2012	Aug 2012	Sep 2012	Feb 2012	Sep 2013	Apr 2014	Jan 2015	Apr 2015	Jun 2015	Sep 2015
AFP (ULN < 5.5 IU/mL)	86	120	153	167	16	3	2	3	2	1.5	1.2

ULN: Upper limit of normal; AFP: Alpha fetoprotein.

Citation: Krastev Z, Jelev D, Antonov K, Petkova T, Atanasova E, Zheleva N, Tomov B, Boyanova Y, Mateva L. Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma. World J Gastroenterol 2016; 22(8): 2630-2635
URL: https://www.wjgnet.com/1007-9327/full/v22/i8/2630.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i8.2630